LCM
PFE icon

Lomas Capital Management’s Pfizer PFE Stock Holding History

Lomas Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-468,948
Closed -$15.1M – 40
2016
Q3 		$15.1M Buy
468,948
+94,908
+25% +$3.17M 3.37% 12
2016
Q2 		$12.5M Buy
+374,040
New +$11.9M 2.53% 16

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Lomas Capital Management's PFE Position: Q4 2016 in Review

Lomas Capital Management sold out of Pfizer (PFE) in Q4 2016, closing a stake of 468,948 shares — an estimated $15.1M sold.

Lomas Capital Management first reported a position in PFE in Q2 2016 and held it in 2 quarters. The position peaked at $15.1M in Q3 2016. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • Lomas Capital Management reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
  • Lomas Capital Management sold 468,948 Pfizer shares in Q4 2016, an estimated $15.1M.
  • Lomas Capital Management first reported a position in Pfizer in Q2 2016 and held it in 2 quarters.
  • Lomas Capital Management's Pfizer position peaked at $15.1M in Q3 2016.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Lomas Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.